Waters (WAT) Leaves Russell Indexes As Investors Weigh Whether The Valuation Case Still Holds

Simply Wall St.07-05

Waters (WAT) has just been removed from several Russell growth and defensive indexes, a technical event that can influence how index-linked funds hold or sell the stock in coming months. See our ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2649269270?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","is_english":true,"pubTime":"2026-07-05 04:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2649269270","market":"hk","top_or_hot":-1,"title":"Waters (WAT) Leaves Russell Indexes As Investors Weigh Whether The Valuation Case Still Holds","media":"Simply Wall St.","content":"<div>\n<p>Waters (WAT) has just been removed from several Russell growth and defensive indexes, a technical event that can influence how index-linked funds hold or sell the stock in coming months. See our ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-wat/waters/news/waters-wat-leaves-russell-indexes-as-investors-weigh-whether\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Waters (WAT) Leaves Russell Indexes As Investors Weigh Whether The Valuation Case Still Holds</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWaters (WAT) Leaves Russell Indexes As Investors Weigh Whether The Valuation Case Still Holds\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-05 04:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-wat/waters/news/waters-wat-leaves-russell-indexes-as-investors-weigh-whether><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Waters (WAT) has just been removed from several Russell growth and defensive indexes, a technical event that can influence how index-linked funds hold or sell the stock in coming months. See our ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-wat/waters/news/waters-wat-leaves-russell-indexes-as-investors-weigh-whether\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-wat/waters/news/waters-wat-leaves-russell-indexes-as-investors-weigh-whether","article_id":"2649269270","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-wat/waters/news/waters-wat-leaves-russell-indexes-as-investors-weigh-whether","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2649269270","pubTimestamp":1783197019,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Waters (WAT) has just been removed from several Russell growth and defensive indexes, a technical event that can influence how index-linked funds hold or sell the stock in coming months.\nSee our latest analysis for Waters.\nDespite Waters being dropped from several Russell indexes, recent price action has been relatively firm, with a 90-day share price return of 24.67% and a 1-year total shareholder return of 8.30%. This suggests momentum has picked up after a softer year to date.\nIf you are...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","ISBC":"投资者银行","BK4121":"生命科学工具和服务","LU0690374961.EUR":"FUNDSMITH EQUITY \"R\" (EUR) INC","LU0347712357.USD":"BNP PARIBAS GLOBAL ENVIRONMENT \"C\" (USD) ACC","LU2413666426.HKD":"BNP PARIBAS GLOBAL ENVIRONMENT \"C\" (HKD) ACC","LU1721428933.USD":"法巴全球经典环境基金RH MD Dis","GB00B4LPDJ14.GBP":"FUNDSMITH EQUITY \"R\" (GBP) ACC","WAT.AU":"WATERCO LIMITED","WAT":"沃特世","LU2404859741.USD":"FUNDSMITH EQUITY FUND \"R\" (USD) INC","BK4211":"区域性银行","LU0690374615.EUR":"FUNDSMITH EQUITY \"R\" (EUR) ACC","LU2413666699.HKD":"BNP PARIBAS GLOBAL ENVIRONMENT \"CRH\" (HKDHDG) INC","BK4588":"碎股","BK7118":"消闲用品","LU2404859667.USD":"FUNDSMITH EQUITY FUND \"R\" (USD) ACC","GB00B4QBRK32.GBP":"FUNDSMITH EQUITY \"R\" (GBP) INC"},"translate_title":"随着投资者权衡估值情况是否仍然成立，沃特世(WAT)退出罗素指数","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ISBC":1.5,"WAT":1.5,"WAT.AU":1.5},"content_text":"Waters (WAT) has just been removed from several Russell growth and defensive indexes, a technical event that can influence how index-linked funds hold or sell the stock in coming months. See our latest analysis for Waters. Despite Waters being dropped from several Russell indexes, recent price action has been relatively firm, with a 90-day share price return of 24.67% and a 1-year total shareholder return of 8.30%. This suggests momentum has picked up after a softer year to date. If you are reassessing your watchlist after Waters' index changes, it could be a good moment to broaden your search with the 20 top founder-led companies With Waters stock up 24.67% over 90 days, trading at $379.29 and implying a 23.17% intrinsic discount alongside a modest gap to analyst targets, you need to ask: is there real value here, or is future growth already priced in? AdvertisementMost Popular Narrative: 5.6% Undervalued On the most followed narrative, Waters screens as modestly undervalued, with a fair value estimate of $401.78 versus the recent close at $379.29, and that gap rests on some ambitious growth and profitability assumptions.  The planned combination with BD's Biosciences and Diagnostic Solutions business is expected to accelerate entry into biologics, precision medicine, and cell/gene therapy markets, segments with expanding analytical needs, unlocking new addressable markets and providing a multi-year revenue synergy opportunity, directly impacting future revenues and EPS growth.  Read the complete narrative. Curious what kind of revenue ramp, margin lift, and future earnings multiple sit behind that fair value for Waters? The narrative leans on rapid top line expansion, fatter profit margins, and a rich earnings valuation years out. The full story spells out how those ingredients combine into today’s price gap. Result: Fair Value of $401.78 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, this Waters narrative depends heavily on the smooth integration of BD Biosciences and Diagnostic Solutions, as well as on funding in academic and government markets not weakening further. Find out about the key risks to this Waters narrative. Another View: What Multiples Say About Waters While the SWS DCF model points to Waters trading at a 23.2% discount to its estimated future cash flows, the picture looks different when you just look at earnings. Waters trades on a P/E of 82.8x, compared with a fair ratio of 32.3x, peers at 33x, and the Global Life Sciences industry at 37.1x, which suggests a rich earnings valuation. This raises the question of whether this represents a quality premium that holds or a gap that eventually closes. See what the numbers say about this price, See what the numbers say about this price — find out in our valuation breakdown. NYSE:WAT P/E Ratio as at Jul 2026Next Steps Given the mix of optimism and concern around Waters, it makes sense to look past headlines and work through the numbers yourself. If you want a structured view of both the upsides and the potential red flags investors are focused on, start with these 2 key rewards and 3 important warning signs Looking for more investment ideas beyond Waters? If Waters is already on your radar, do not stop there. Broaden your opportunity set with a few focused stock ideas built from the Simply Wall St Screener.  Target consistent income by checking out companies tagged as potential yield anchors using the 7 dividend fortresses. Hunt for quality at a reasonable price by scanning companies that combine solid fundamentals with attractive pricing in the screener containing 18 high quality undiscovered gems. Prioritize capital preservation and steadier returns by reviewing resilient companies highlighted in the 74 resilient stocks with low risk scores.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Waters might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2649269270","isCrawlerRequest":true}